10 Best Stocks Under $50 to Buy Right Now

2. Pfizer Inc. (NYSE:PFE)

Share Price as of February 20: $25.89

Number of Hedge Fund Holders: 92

Pfizer Inc. (NYSE:PFE) is a leading global pharmaceutical company that researches, manufactures, and markets prescription drugs, vaccines, and consumer healthcare products, with a focus on treatments for a wide variety of medical problems, from common illnesses to uncommon disorders.

On February 11, Jefferies analyst Akash Tewari raised the price target for Pfizer Inc. (NYSE:PFE) from $33 to $34, while maintaining a Buy rating on the company. The change followed the publication of Pfizer’s abstract on mevrometostat (EZH2i) at the American Society of Clinical Oncology Genitourinary (ASCO GU) meeting. Tewari stated that the newly revealed findings may have good implications for Pfizer’s current Phase 3 studies in both post-abiraterone and first-line metastatic castration-resistant prostate cancer (mCRPC) situations.